Cataract surgery with implantation of a high‐add intraocular lens LENTIS® MAX LS‐313 MF80 in end‐stage, age‐related macular degeneration: A case report of magnifying surgery.

Key Clinical Message: A new treatment option for cataracts and advanced ARMD: the simultaneous intravitreal injection of anti‐vascular endothelial growth factor and implantation of a high‐add IOL. We believe major opportunities arise from a new subcategory in cataract surgery—called magnifying surgery (MAGS). Our case proves the potential of this brand‐new technology. A new treatment option for cataracts and advanced ARMD: the simultaneous intravitreal injection of anti‐vascular endothelial growth factor and implantation of a high‐add IOL. We believe major opportunities arise from a new subcategory in cataract surgery—called magnifying surgery (MAGS). Our case proves the potential of this brand‐new technology. [ABSTRACT FROM AUTHOR]